Ozurdex as Adjunct to Avastin Compared to Avastin Alone in Treatment of Patients With Diabetic Macular Edema
Completed · Phase 4
Conditions studied: Diabetic Macular Edema
In brief
The investigators hypothesize that a combination treatment with Avastin and Ozurdex will result in a more rapid improvement of visual acuity compared to the use of Avastin alone.
Key facts
- Study ID
- NCT01309451
- Run by
- Maturi, Raj K., M.D., P.C.
- People needed
- 40
- Starts
- 2011-03-01
- Expected to finish
- 2013-04-01
- Last updated by the study team
- 2014-10-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Male or female age 18 years or older
- Type 1 or type 2 diabetes
- BCVA score of >24 and <78 letters
- Presence of DME defined as Optical Coherence Tomography Center Subfield Thickness (OCT CST) >250microns
You may not qualify if…
- Anti-VEGF intravitreal treatment in last 4 weeks
- Intravitreal steroid treatment in the last 8 weeks
- PRP or Focal laser in last 4 months
- Active iris neovascularization
Where it is running
- Raj K. Maturi, MD — Indianapolis, Indiana, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.